Prioritize your patients when everything is a priority


Genetic testing for hereditary cancers can identify
high-risk patients who may require immediate care.


Over the past year, it’s likely that your patients with cancer have had important appointments canceled and/or delayed.

Navigating the backlog of visits may be challenging, especially when considering the uncertainty of disease progression and how it can affect treatment strategies or outcomes.


Genetic testing is recommended by professional guidelines for patients with breast, ovarian, endometrial, colorectal, pancreatic, and prostate cancers.

Results may help you to better stratify patients based on risk; direct you to targeted therapies or specific surgical interventions; and even qualify patients for clinical trials.


Patients with ovarian (epithelial, ovarian, tubal, and peritoneal) and pancreatic cancers should consider genetic testing

1 in 10

Breast cancers have hereditary causes

1 in 6

Patients with prostate cancer have a germline variant

1 in 5

Patients with pancreatic cancer have a germline variant

The Invitae advantage

Genetic testing, simplified. Invitae offers expertly curated tests, access to a telemedicine-friendly genetic assistant, and affordable options for patients with or without insurance.

Illustration of two patients

Comprehensive test menus

Our genetic tests offer customizable hereditary cancer panels that provide clear results.

Additionally, saliva tests can be mailed directly to patients, so they can submit a sample from the comfort and safety of home.

Illustration of patient

Beyond telemedicine

Gia, our HIPAA-compliant genetic information assistant, provides an end-to-end genetic testing framework that helps identify patients who could benefit from germline genetic testing.

After identifying patients, Gia facilitates patient education and answers questions about testing.

Illustration of patients

Transparent pricing

In-network for more than 300 million medically insured lives, Invitae also offers flat patient-pay rates for those not covered by insurance.

This allows more patients to benefit from genetic testing, without the hurdle of cost.

Image: Dozens of patients